Gábor Koncz

ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Venues

Cancer immunology, immunotherapy : CII

Stem cells international

Cell death & disease

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Anett Mázló, Viktória Jenei, Sára Burai, Tamás Molnár, Attila Bácsi, Gábor Koncz
Types of necroinflammation, the effect of cell death modalities on sterile inflammation. Cell death & disease 13 (5) (2022)
Viktória Jenei, Sára Burai, Tamás Molnár, Balázs Kardos, Rebeka Mácsik, Márta Tóth, Zsuzsanna Debreceni, Attila Bácsi, Anett Mázló, Gábor Koncz
Comparison of the immunomodulatory potential of platinum-based anti-cancer drugs and anthracyclins on human monocyte-derived cells. Cancer chemotherapy and pharmacology (2022)
Tamás Molnár, Petra Pallagi, Bálint Tél, Róbert Király, Eszter Csoma, Viktória Jenei, Zsófia Varga, Péter Gogolák, Anne Odile Hueber, Zoltán Máté, Ferenc Erdélyi, Gábor Szabó, Aladár Pettkó-Szandtner, Attila Bácsi, László Virág, József Maléth, Gábor Koncz
Caspase-9 acts as a regulator of necroptotic cell death. The FEBS journal 288 (22) (2021)
Zoltán J Veréb, Anett Mázló, Attila Szabó, Szilárd Póliska, Attila Kiss, Krisztina Litauszky, Gábor Koncz, Zoltán Boda, Éva Rajnavölgyi, Attila Bacsi
Vessel Wall-Derived Mesenchymal Stromal Cells Share Similar Differentiation Potential and Immunomodulatory Properties with Bone Marrow-Derived Stromal Cells. Stem cells international 2020 (2020)
Zsófia Varga, Tamás Molnár, Anett Mázló, Ramóna Kovács, Viktória Jenei, Krisztina Kerekes, Attila Bácsi, Gábor Koncz
Differences in the sensitivity of classically and alternatively activated macrophages to TAK1 inhibitor-induced necroptosis. Cancer immunology, immunotherapy : CII 69 (11) (2020)

Gábor Koncz.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Gábor Koncz